Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data
dc.contributor.author | Cohen, P | en_US |
dc.contributor.author | Powell, A | en_US |
dc.contributor.author | Böhm, S | en_US |
dc.contributor.author | Gilks, CB | en_US |
dc.contributor.author | Stewart, CJR | en_US |
dc.contributor.author | Meniawy, TM | en_US |
dc.contributor.author | Bulsara, M | en_US |
dc.contributor.author | Avril, S | en_US |
dc.contributor.author | Brockbank, EC | en_US |
dc.contributor.author | Bosse, T | en_US |
dc.contributor.author | Focchi, GRDA | en_US |
dc.contributor.author | Ganesan, R | en_US |
dc.contributor.author | Glasspool, RM | en_US |
dc.contributor.author | Howitt, BE | en_US |
dc.contributor.author | Kim, H-S | en_US |
dc.contributor.author | Lee, J-Y | en_US |
dc.contributor.author | Lee, ND | en_US |
dc.contributor.author | Lockley, M | en_US |
dc.contributor.author | Manchanda, R | en_US |
dc.contributor.author | Mandalia, T | en_US |
dc.contributor.author | McCluggage, WG | en_US |
dc.contributor.author | McNeish, I | en_US |
dc.contributor.author | Midha, D | en_US |
dc.contributor.author | Srinivasan, R | en_US |
dc.contributor.author | Tan, YY | en_US |
dc.contributor.author | van der Griend, R | en_US |
dc.contributor.author | Yunokawa, M | en_US |
dc.contributor.author | Zannoni, GF | en_US |
dc.contributor.author | Network, HGSCCRSC | en_US |
dc.contributor.author | Singh, N | en_US |
dc.date.accessioned | 2020-07-23T15:00:43Z | |
dc.date.issued | 2018-07-11 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/65809 | |
dc.rights | Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | |
dc.subject | High grade serous carcinoma; ovarian cancer; chemotherapy response score; neoadjuvant chemotherapy; prognosis; biomarker | en_US |
dc.title | Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data | en_US |
dc.type | Article | |
dc.rights.holder | © 2019 The Authors. Published by Elsevier Inc. | |
pubs.notes | Not known | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1179]